Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Landuzzi

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.
Cancer Research|March 5, 2004
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cellsStefania Croci, Lorena Landuzzi, Annalisa Astolfi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcomaMaria C Manara, Lorena Landuzzi, Patrizia Nanni, et al.
Journal of Hematology & Oncology|October 12, 2022
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortalityCarlo Sorrentino, Luigi D'Antonio, Stefania Livia Ciummo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependentPatrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Vaccine|May 17, 2011
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccinesLorena Landuzzi, Agnese Antognoli, Giordano Nicoletti, et al.
Cancer Research|November 17, 2007
Antimetastatic activity of a preventive cancer vaccinePatrizia Nanni, Giordano Nicoletti, Arianna Palladini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditionsKatia Scotlandi, Maria Cristina Manara, Rosaria Strammiello, et al.
The American Journal of Pathology|March 29, 2005
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinomaAnnalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.
Cancer Research|March 5, 2004
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cellsStefania Croci, Lorena Landuzzi, Annalisa Astolfi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcomaMaria C Manara, Lorena Landuzzi, Patrizia Nanni, et al.
Journal of Hematology & Oncology|October 12, 2022
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortalityCarlo Sorrentino, Luigi D'Antonio, Stefania Livia Ciummo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependentPatrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Vaccine|May 17, 2011
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccinesLorena Landuzzi, Agnese Antognoli, Giordano Nicoletti, et al.
Cancer Research|November 17, 2007
Antimetastatic activity of a preventive cancer vaccinePatrizia Nanni, Giordano Nicoletti, Arianna Palladini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditionsKatia Scotlandi, Maria Cristina Manara, Rosaria Strammiello, et al.
The American Journal of Pathology|March 29, 2005
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinomaAnnalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, et al.
Pageof 9